Journal article
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors
Abstract
Aim: To evaluate the correlation between venous thromboembolism events (VTEs) and immune checkpoint inhibitor (ICI)-based regimens. Methods: This is a retrospective study of 403 patients with advanced cancer on ICI-based regimens. Results: We report 8% VTE incidence post-ICI initiation over a median of 11.1 months of follow-up. Compared with single-agent ICI, dual-ICI was significantly correlated with higher incidence of VTE (odds ratio [OR]: …
Authors
Kartolo A; Yeung C; Moffat GT; Hanna L; Hopman W; Baetz T
Journal
Immunotherapy, Vol. 14, No. 1, pp. 23–30
Publisher
Taylor & Francis
Publication Date
1 2022
DOI
10.2217/imt-2021-0151
ISSN
1750-743X